Speakers from Touchstone Exploration, Shanta Gold, Savannah Resources and Kavango Resources feature in our Natural Resources webinar on May 25th. Please register here.

Less Ads, More Data, More Tools Register for FREE

UK signs deal with Wockhardt to boost vaccine manufacturing process

Mon, 3rd Aug 2020 10:24

LONDON, Aug 3 (Reuters) - Britain said on Monday it had
partnered with Indian drugmaker Wockhardt to boost
COVID-19 vaccine manufacturing and hopes the firm's could start
work as soon as next month.

The agreement would see Wockhardt carry out the ‘fill and
finish’ stage of the manufacturing process, which involves
dispensing the manufactured vaccine substance into vials ready
for it to be distributed.

"Today we have secured additional capacity to manufacture
millions of doses of multiple COVID-19 candidates, guaranteeing
the supply of vaccines we need to protect people across the UK
rapidly and in large numbers," said British business minister
Alok Sharma in a statement.
(Reporting by Costas Pitas; editing by William James)

Related Shares

More News

LONDON MARKET CLOSE: Stocks plunge as global inflation fears return

LONDON MARKET CLOSE: Stocks plunge as global inflation fears return

Today 17:00

AstraZeneca shareholders give green light to Alexion takeover

AstraZeneca shareholders give green light to Alexion takeover

Today 14:25

AstraZeneca shareholders approve Alexion acquisition

(Sharecast News) - AstraZeneca's acquisition of Alexion Pharmaceuticals is set to close in the third quarter after shareholders voted in favour of the deal.

Today 13:59

Tuesday broker round-up

(Sharecast News) - Safestore: Liberum upgrades to buy with a target price of 1,060p.

Today 13:31

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.